MedTrace Logo

Electroporation for Cancer Treatment Real World Registry

NCT04929912 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-01-29

No results posted yet for this study

Summary

This registry aims to assess real-world long-term disease outcomes for patients treated using reversible electroporation and a chemotherapeutic or calcium; in particular tumour response rates and recurrence rates. The study also aims to characterise side effects and the occurrence of Adverse Events and their relationship to the treatment.

Conditions

Sponsors & Collaborators

  • Mirai Medical

    lead INDUSTRY

Principal Investigators

  • SEAN H Kinsella · Mirai Medical

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-24
Primary Completion
2026-12-24
Completion
2036-06-24

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04929912 on ClinicalTrials.gov